NeuroServo
PrivateLast Round
Seed
Jun 20, 2023
Total Funding Raised
$1.69M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroServo operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Seed round in June 2023.
NeuroServo is a monitoring equipment company that has developed VEEGix, an innovative medical device allowing instant analysis of prefrontal brain waves for use in intensive care units, operating rooms, and emergency departments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroServo Comparables
Compare NeuroServo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ceribell | 83% | |
| Epitel, Inc. | 81% | |
| Gentle Neuro | 81% |
For institutional investors. Book with your work email.
NeuroServo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 20, 2023 | ||||
| Accelerator | Jun 15, 2021 | ||||
| Grant | Aug 5, 2020 | ||||
| Accelerator | Dec 18, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroServo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Accelerator, Seed |
| Desjardins Capital | Seed |
| Gouvernement du Québec | Grant |
| Centech | Accelerator |
| Centre for Aging and Brain Health Innovation | Seed |
| Medical Alley Association | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 146% MoM.
- Jun 20, 2023
$1.65M round led by Desjardins Capital and CABHI.
For institutional investors. Book with your work email.
NeuroServo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroServo's valuation, stock price, and market status.
Is NeuroServo a public or private company?
NeuroServo is a private company.
What is the current stock price of NeuroServo?
NeuroServo is a private company, so its shares have no public market price. Caplight tracks NeuroServo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroServo worth (valuation)?
Valuation information for NeuroServo is not publicly available.
Can I buy NeuroServo stock?
NeuroServo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroServo's last funding round?
NeuroServo's most recent funding round was Seed on June 20, 2023.
Who are the main investors in NeuroServo?
Key investors in NeuroServo include Investissement Québec, Desjardins Capital, Centre for Aging and Brain Health Innovation.
Will NeuroServo IPO soon?
No public IPO plans have been announced for NeuroServo.
How can I track NeuroServo secondary market activity?
Caplight tracks bids, offers, and trades in NeuroServo's shares on secondary markets.